1. ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM. (11th November 2019) Authors: Ahluwalia, Manmeet; Grabowski, Matthew; Alban, Tyler; Otvos, Balint; Bayik, Defne; Saeed Bamashmos, Anas; Rayman, Patricia; Diaz-Montero, Marcela; Reardon, David; Wen, Patrick; Peereboom, David; Lathia, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. (27th May 2016) Authors: Otvos, Balint; Silver, Daniel J.; Mulkearns-Hubert, Erin E.; Alvarado, Alvaro G.; Turaga, Soumya M.; Sorensen, Mia D.; Rayman, Patricia; Flavahan, William A; Hale, James S.; Stoltz, Kevin; Sinyuk, Maksim; Wu, Qiulian; Jarrar, Awad; Kim, Sung-Hak; Fox, Paul L.; Nakano, Ichiro; Rich, Jeremy N.; Ran... Journal: Stem cells Issue: Volume 34:Number 8(2016:Aug.) Page Start: 2026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. (27th May 2016) Authors: Otvos, Balint; Silver, Daniel J.; Mulkearns‐Hubert, Erin E.; Alvarado, Alvaro G.; Turaga, Soumya M.; Sorensen, Mia D.; Rayman, Patricia; Flavahan, William A; Hale, James S.; Stoltz, Kevin; Sinyuk, Maksim; Wu, Qiulian; Jarrar, Awad; Kim, Sung‐Hak; Fox, Paul L.; Nakano, Ichiro; Rich, Jeremy N.; Ran... Journal: Stem cells Issue: Volume 34:Number 8(2016:Aug.) Page Start: 2026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy. Issue 7 (8th October 2013) Authors: Jaini, Ritika; Rayman, Patricia; Cohen, Peter A.; Finke, James H.; Tuohy, Vincent K. Journal: International journal of cancer Issue: Volume 134:Issue 7(2014:Apr. 01) Page Start: 1695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ex vivo conditioning with IL-12 decreases T cell sensitivity to intratumoral INF-γ-induced apoptosis following adoptive transfer. (4th November 2015) Authors: Diaz-Montero, C Marcela; Tannenbaum, Charles; Rayman, Patricia; Pavicic, Paul; Sub Kim, Jin; Ernstoff, Marc; Finke, James Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ex vivo conditioning with IL-12 decreases T cell sensitivity to intratumoral INF-γ-induced apoptosis following adoptive transfer. Issue 2 (December 2015) Authors: Diaz-Montero, C; Tannenbaum, Charles; Rayman, Patricia; Pavicic, Paul; Sub Kim, Jin; Ernstoff, Marc; Finke, James Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model. (4th November 2015) Authors: Rayman, Patricia; Diaz-Montero, C Marcela; Yang, Yu; Rini, Brian; Elson, Paul; Finke, James Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model. Issue 2 (December 2015) Authors: Rayman, Patricia; Diaz-Montero, C; Yang, Yu; Rini, Brian; Elson, Paul; Finke, James Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Proangiogenic neutrophilic-myeloid-derived suppressor cells emerge via two parallel pathways in renal cell carcinoma and melanoma. (7th November 2013) Authors: Ko, Jennifer; Rayman, Patricia; Obery, Dana; Lindner, Daniel; Borden, Ernest; Finke, James Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. Issue 1 (16th May 2018) Authors: Sun, Lillian; Funchain, Pauline; Song, Jung Min; Rayman, Patricia; Tannenbaum, Charles; Ko, Jennifer; Mcnamara, Michael; Marcela Diaz-Montero, C.; Gastman, Brian Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗